Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
Rachel A. Davidowitz, … , Ronny Drapkin, Joan S. Brugge
Rachel A. Davidowitz, … , Ronny Drapkin, Joan S. Brugge
Published April 24, 2014
Citation Information: J Clin Invest. 2014;124(6):2611-2625. https://doi.org/10.1172/JCI69815.
View: Text | PDF
Research Article Article has an altmetric score of 20

Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance

  • Text
  • PDF
Abstract

Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used an in vitro assay that models the initial step of ovarian cancer metastasis, clearance of the mesothelial cell layer, to examine the clearance ability of a large panel of both established and primary ovarian tumor cells. Comparison of the gene and protein expression profiles of clearance-competent and clearance-incompetent cells revealed that mesenchymal genes are enriched in tumor populations that display strong clearance activity, while epithelial genes are enriched in those with weak or undetectable activity. Overexpression of transcription factors SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mesothelial clearance in cell lines with weak activity, while knockdown of the EMT-regulatory transcription factors TWIST1 and ZEB1 attenuated mesothelial clearance in ovarian cancer cell lines with strong activity. These findings provide important insights into the mechanisms associated with metastatic progression of ovarian cancer and suggest that inhibiting pathways that drive mesenchymal programs may suppress tumor cell invasion of peritoneal tissues.

Authors

Rachel A. Davidowitz, Laura M. Selfors, Marcin P. Iwanicki, Kevin M. Elias, Alison Karst, Huiying Piao, Tan A. Ince, Michael G. Drage, Judy Dering, Gottfried E. Konecny, Ursula Matulonis, Gordon B. Mills, Dennis J. Slamon, Ronny Drapkin, Joan S. Brugge

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 1 7 11 9 8 9 10 10 8 7 9 4 93
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (93)

Title and authors Publication Year
APOBEC3A drives ovarian cancer metastasis by altering epithelial-to-mesenchymal transition
Jessica Devenport, Thi Tran, Brooke R. Harris, Dylan Fingerman, Rachel A. DeWeerd, Lojain H Elkhidir, Danielle LaVigne, Katherine Fuh, Lulu Sun, Jeffrey J. Bednarski, Ronny Drapkin, Mary M Mullen, Abby M. Green
JCI Insight 2025
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells
Hunter Reavis, Stefan Gysler, Grace McKenney, Matthew Knarr, Hannah Lusk, Priyanka Rawat, Hannah Rendulich, Marilyn Mitchell, Dara S. Berger, Jamie S. Moon, Suyeon Ryu, Monica Mainigi, Marcin Iwanicki, Dave Hoon, Laura Sanchez, Ronny Drapkin
JCI Insight 2024
Harnessing function of EMT in cancer drug resistance: a metastasis regulator determines chemotherapy response.
Ebrahimi N, Manavi MS, Faghihkhorasani F, Fakhr SS, Baei FJ, Khorasani FF, Zare MM, Far NP, Rezaei-Tazangi F, Ren J, Reiter RJ, Nabavi N, Aref AR, Chen C, Ertas YN, Lu Q
Cancer metastasis reviews 2024
Reciprocal crosstalk between Th17 and mesothelial cells promotes metastasis‐associated adhesion of ovarian cancer cells
Neuhaus F, Lieber S, Shinkevich V, Steitz AM, Raifer H, Roth K, Finkernagel F, Worzfeld T, Burchert A, Keber C, Nist A, Stiewe T, Reinartz S, Beutgen VM, Graumann J, Pauck K, Garn H, Gaida M, Müller R, Huber M
Clinical and Translational Medicine 2024
Enhancing PKA-dependent mesothelial barrier integrity reduces ovarian cancer transmesothelial migration via inhibition of contractility
Jazwinska DE, Cho Y, Zervantonakis IK
iScience 2024
The Gut Microbiome in Aging and Ovarian Cancer
Dominique GM, Hammond C, Stack MS
Aging and cancer 2024
LCP1 promotes ovarian cancer cell resistance to olaparib by activating the JAK2/STAT3 signalling pathway
Gai M, Zhao L, Li H, Jin G, Li W, Wang F, Liu M
Cancer Biology & Therapy 2024
Plakin Expression in Serous Epithelial Ovarian Cancer Has the Potential to Impede Metastatic Spread and Epithelial–Mesenchymal Transition: A Comparative Expression Analysis of Immunohistochemical and In Silico Datasets
Wesley T, Escalona RM, Kannourakis G, Ahmed N
Cancers 2024
MNRR1 is a driver of ovarian cancer progression
Chehade H, Purandare N, Fox A, Adzibolosu N, Jayee S, Singh A, Tedja R, Gogoi R, Aras S, Grossman LI, Mor G, Alvero AB
Translational oncology 2023
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Sato S, Gillette M, de Santiago PR, Kuhn E, Burgess M, Doucette K, Feng Y, Mendez-Dorantes C, Ippoliti PJ, Hobday S, Mitchell MA, Doberstein K, Gysler SM, Hirsch MS, Schwartz L, Birrer MJ, Skates SJ, Burns KH, Carr SA, Drapkin R
Scientific Reports 2023
Model of collective detachment in high-grade serous ovarian cancer demonstrates that tumor spheroids produce ECM to support metastatic processes
Micek HM, Rosenstock L, Ma Y, Hielsberg C, Montemorano L, Gari MK, Ponik SM, Kreeger PK
2023
Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy
Liu Y, Yang J, Hilliard TS, Wang Z, Johnson J, Wang W, Harper EI, Ott C, O\u2019Brien C, Campbell L, Crowley B, Grisoli S, Stavrou NM, Juncker-Jensen A, Stack MS
Journal of experimental & clinical cancer research : CR 2023
Positional influence on cellular transcriptional identity revealed through spatially segmented single-cell transcriptomics
Morse DB, Michalowski AM, Ceribelli M, Jonghe JD, Vias M, Riley D, Davies-Hill T, Voss T, Pittaluga S, Muus C, Liu J, Boyle S, Weitz DA, Brenton JD, Buenrostro JD, Knowles TP, Thomas CJ
Cell Systems 2023
Exploiting a living biobank to delineate mechanisms underlying disease-specific chromosome instability.
Nelson L, Barnes BM, Tighe A, Littler S, Coulson-Gilmer C, Golder A, Desai S, Morgan RD, McGrail JC, Taylor SS
Chromosome Research 2023
Single‐cell RNA sequencing captures patient‐level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions
Whitfield HJ, Berthelet J, Mangiola S, Bell C, Anderson RL, Pal B, Yeo B, Papenfuss AT, Merino D, Davis MJ
Clinical and Translational Medicine 2023
Glucocorticoid Receptor Activation in Lobular Breast Cancer Is Associated with Reduced Cell Proliferation and Promotion of Metastases
Porter BA, Frerich C, Lainé M, Clark AB, Durdana I, Lee J, Taya M, Sahoo S, Greene GL, Bennett L, Conzen SD
Cancers 2023
Genetic and Functional Modifications Associated with Ovarian Cancer Cell Aggregation and Limited Culture Conditions
Grieco JP, Compton SL, Davis GN, Guinan J, Schmelz EM
International journal of molecular sciences 2023
Defining the Role of Metastasis-Initiating Cells in Promoting Carcinogenesis in Ovarian Cancer.
Wang J, Ford JC, Mitra AK
Biology 2023
Stromal DDR2 promotes ovarian cancer metastasis through regulation of metabolism and secretion of extracellular matrix proteins
Schab AM, Greenwade MM, Stock E, Lomonosova E, Cho K, Grither WR, Noia H, Wilke D, Mullen MM, Hagemann AR, Hagemann IS, Thaker PH, Kuroki LM, McCourt CK, Khabele D, Powell MA, Mutch DG, Zhao P, Shriver LP, Patti GJ, Longmore GD, Fuh KC
Molecular cancer research : MCR 2023
Ovarian Cancer Cells in Ascites Form Aggregates That Display a Hybrid Epithelial-Mesenchymal Phenotype and Allows Survival and Proliferation of Metastasizing Cells
S Capellero, J Erriquez, C Battistini, R Porporato, G Scotto, F Borella, M Renzo, G Valabrega, M Olivero
International journal of molecular sciences 2022
Wnt5A and TGFβ1 Converges through YAP1 Activity and Integrin Alpha v Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation
Z Dehghani-Ghobadi, S Hasani, E Arefian, G Hossein
Cells 2022
Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion
Compton SL, Grieco JP, Gollamudi B, Bae E, Van Mullekom JH, Schmelz EM
Cancers 2022
Gata6+ resident peritoneal macrophages promote the growth of liver metastasis
Hossain M, Shim R, Lee WY, Sharpe AH, Kubes P
Nature Communications 2022
DDR2 Expression in Cancer-Associated Fibroblasts Promotes Ovarian Cancer Tumor Invasion and Metastasis through Periostin-ITGB1
Akinjiyan FA, Dave RM, Alpert E, Longmore GD, Fuh KC
Cancers 2022
Compound C Inhibits Ovarian Cancer Progression via PI3K-AKT-mTOR-NFκB Pathway.
Ghoneum A, Gonzalez D, Afify H, Shu J, Hegarty A, Adisa J, Kelly M, Lentz S, Salsbury F, Said N
Cancers 2022
Metabolic Reprogramming and Lipophagy Mediates Survival of Ascites Derived Metastatic Ovarian Cancer Cells.
S SK, N Swamy S, Devaraj VR, Premalatha CS, Pallavi VR, Sagar BC, Shinde DD, Gawari R
Asian Pacific Journal of Cancer Prevention 2022
Agent-based modeling predicts RAC1 is critical for ovarian cancer metastasis.
Rivera M, Toledo-Jacobo L, Romero E, Oprea TI, Moses ME, Hudson LG, Wandinger-Ness A, Grimes MM
Molecular biology of the cell 2022
Ovarian Cancer Ascites Inhibits Transcriptional Activation of Natural Killer Cells Partly Through CA125
Fraser CC, Jia B, Hu G, Johani LI, Fritz-Klaus R, Ham JD, Fichorova RN, Elias KM, Cramer DW, Patankar MS, Chen J
Journal of immunology (Baltimore, Md. : 1950) 2022
Cancer associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, Chenkai Ma, Suchitra Natarajan, Joshua T Eggold, Yiren Xiao, Katherine C Fuh, Venkatesh Krishnan, Annika Enejder, Sarah Heilshorn, Oliver Dorigo, Erinn B. Rankin
Journal of Clinical Investigation 2021
TGFβ signaling networks in ovarian cancer progression and plasticity
A Kumari, Z Shonibare, M Monavarian, RC Arend, NY Lee, GJ Inman, K Mythreye
Clinical & Experimental Metastasis 2021
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
J Mei, H Tian, HS Huang, CF Hsu, Y Liou, N Wu, W Zhang, TY Chu
Cell Proliferation 2021
ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer
S Bhat, SP Kabekkodu, D Adiga, R Fernandes, V Shukla, P Bhandari, D Pandey, K Sharan, K Satyamoorthy
Cell Biology and Toxicology 2021
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
G Xu, W Kong, Z Fang, Y Fan, Y Yin, SA Sullivan, AQ Tran, LH Clark, W Sun, T Hao, L Zhao, C Zhou, VL Bae-Jump
Frontiers in Oncology 2021
Topological defects in the mesothelium suppress ovarian cancer cell clearance
J Zhang, N Yang, PK Kreeger, J Notbohm
2021
Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology
A Martinez, MS Buckley, CB Scalise, D Wang, AA Katre, MJ Birrer, JL Berry, RC Arend
Journal of Tissue Engineering 2021
Ovarian Cancer-Driven Mesothelial-to-Mesenchymal Transition is Triggered by the Endothelin-1/β-arr1 Axis
DD Rio, I Masi, V Caprara, F Spadaro, F Ottavi, R Strippoli, P Sandoval, M López-Cabrera, RS de la Cuesta, A Bagnato, L Rosanò
Frontiers in Cell and Developmental Biology 2021
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
R Coelho, S Ricardo, AL Amaral, YL Huang, M Nunes, JP Neves, N Mendes, MN López, C Bartosch, V Ferreira, R Portugal, JM Lopes, R Almeida, V Heinzelmann-Schwarz, F Jacob, L David
Oncogenesis 2020
Transient commensal clonal interactions can drive tumor metastasis
SN Amara, HJ Kuiken, LM Selfors, T Butler, ML Leung, CT Leung, EP Kuhn, T Kolarova, C Hage, K Ganesh, R Panayiotou, R Foster, BR Rueda, A Aktipis, P Spellman, TA Ince, J Xiu, M Oberley, Z Gatalica, N Navin, GB Mills, RT Bronson, JS Brugge
Nature Communications 2020
Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells
M Kang, KY Chong, TM Hartwich, F Bi, AK Witham, D Patrick, MJ Morrisson, SL Cady, AP Cerchia, D Kelk, Y Liu, J Nucci, O Madarikan, D Ueno, BM Shuch, Y Yang-Hartwich
Oncogenesis 2020
Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis
YL Huang, CY Liang, D Ritz, R Coelho, D Septiadi, M Estermann, C Cumin, N Rimmer, A Schötzau, MN López, A Fedier, M Konantz, T Vlajnic, D Calabrese, C Lengerke, L David, B Rothen-Rutishauser, F Jacob, V Heinzelmann-Schwarz
eLife 2020
L1 Cell Adhesion Molecule Confers Radioresistance to Ovarian Cancer and Defines a New Cancer Stem Cell Population
N Terraneo, F Jacob, C Peitzsch, A Dubrovska, C Krudewig, YL Huang, V Heinzelmann-Schwarz, R Schibli, M Béhé, J Grünberg
Cancers 2020
Lysophosphatidic acid modulates ovarian cancer multicellular aggregate assembly and metastatic dissemination
Y Klymenko, B Bos, L Campbell, E Loughran, Y Liu, J Yang, O Kim, MS Stack
Scientific Reports 2020
The Capacity of High-Grade Serous Ovarian Cancer Cells to Form Multicellular Structures Spontaneously along Disease Progression Correlates with Their Orthotopic Tumorigenicity in Immunosuppressed Mice
A Goyeneche, MA Lisio, L Fu, R Srinivasan, JV Capuccino, Z Gao, C Telleria
Cancers 2020
A single-cell landscape of high-grade serous ovarian cancer
B Izar, I Tirosh, EH Stover, I Wakiro, MS Cuoco, I Alter, C Rodman, R Leeson, MJ Su, P Shah, M Iwanicki, SR Walker, A Kanodia, JC Melms, S Mei, JR Lin, CB Porter, M Slyper, J Waldman, L Jerby-Arnon, O Ashenberg, TJ Brinker, C Mills, M Rogava, S Vigneau, PK Sorger, LA Garraway, PA Konstantinopoulos, JF Liu, U Matulonis, BE Johnson, O Rozenblatt-Rosen, A Rotem, A Regev
Nature Medicine 2020
SUSD2 expression correlates with decreased metastasis and increased survival in a high-grade serous ovarian cancer xenograft murine model
JN Sheets, ME Patrick, KA Egland
Oncotarget 2020
Ovarian Cancer Dissemination—A Cell Biologist’s Perspective
S Farsinejad, T Cattabiani, T Muranen, M Iwanicki
Cancers 2019
Productive Cross-Talk with the Microenvironment: A Critical Step in Ovarian Cancer Metastasis
Aziz, Agarwal, Dasari, Mitra
Cancers 2019
Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis
S Natarajan, KM Foreman, MI Soriano, NS Rossen, H Shehade, DR Fregoso, JT Eggold, V Krishnan, O Dorigo, AJ Krieg, SC Heilshorn, S Sinha, KC Fuh, EB Rankin
Cancer research 2019
Metastasis Organotropism: Redefining the Congenial Soil
Y Gao, I Bado, H Wang, W Zhang, JM Rosen, XH Zhang
Developmental Cell 2019
Identification of different gene expressions between diffuse- and intestinal-type spheroid-forming gastric cancer cells
JW Lee, JS Sung, YS Park, S Chung, YH Kim
Gastric Cancer 2019
Methods for Systematic Identification of Membrane Proteins for Specific Capture of Cancer-Derived Extracellular Vesicles
MP Zaborowski, K Lee, YJ Na, A Sammarco, X Zhang, M Iwanicki, PS Cheah, HY Lin, M Zinter, CY Chou, G Fulci, BA Tannous, CP Lai, MJ Birrer, R Weissleder, H Lee, XO Breakefield
Cell Reports 2019
Inhibitory effect of carbonyl reductase 1 against peritoneal progression of ovarian cancer: evaluation by ex vivo 3D-human peritoneal model
H Oikiri, Y Asano, M Matsusaki, M Akashi, H Shimoda, Y Yokoyama
Molecular Biology Reports 2019
USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability
M Sonego, I Pellarin, A Costa, GL Vinciguerra, M Coan, A Kraut, S DAndrea, A DallAcqua, DC Castillo-Tong, D Califano, S Losito, R Spizzo, Y Couté, A Vecchione, B Belletti, M Schiappacassi, G Baldassarre
Science Advances 2019
Exosomes promote pre-metastatic niche formation in ovarian cancer
W Feng, DC Dean, FJ Hornicek, H Shi, Z Duan
Molecular Cancer 2019
A biomimetic pancreatic cancer on-chip reveals endothelial ablation via ALK7 signaling
DH Nguyen, E Lee, S Alimperti, RJ Norgard, A Wong, JJ Lee, J Eyckmans, BZ Stanger, CS Chen
Science Advances 2019
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
SA Habyan, C Kalos, J Szymborski, L McCaffrey
Oncogene 2018
TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis
WR Grither, LM Divine, EH Meller, DJ Wilke, RA Desai, AJ Loza, P Zhao, A Lohrey, GD Longmore, KC Fuh
Oncogene 2018
Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
A Ghoneum, H Afify, Z Salih, M Kelly, N Said
Cancer Medicine 2018
Role of tumor microenvironment in ovarian cancer pathobiology
A Ghoneum, H Afify, Z Salih, M Kelly, N Said
Oncotarget 2018
Ovarian Cancers: Genetic Abnormalities, Tumor Heterogeneity and Progression, Clonal Evolution and Cancer Stem Cells
U Testa, E Petrucci, L Pasquini, G Castelli, E Pelosi
Medicines 2018
Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment
ML Drakes, PJ Stiff
Cancers 2018
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
N Nwani, L Sima, W Nieves-Neira, D Matei
Cancers 2018
Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours
R Coelho, L Marcos-Silva, N Mendes, D Pereira, C Brito, F Jacob, C Steentoft, U Mandel, H Clausen, L David, S Ricardo
International journal of molecular sciences 2018
ADH1B promotes mesothelial clearance and ovarian cancer infiltration
KM Gharpure, OD Lara, Y Wen, S Pradeep, C LaFargue, C Ivan, R Rupaimoole, W Hu, LS Mangala, SY Wu, AS Nagaraja, K Baggerly, AK Sood
Oncotarget 2018
Modeling the effect of ascites-induced compression on ovarian cancer multicellular aggregates
Y Klymenko, RB Wates, H Weiss-Bilka, R Lombard, Y Liu, L Campbell, O Kim, D Wagner, MJ Ravosa, MS Stack
Disease models & mechanisms 2018
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
T Worzfeld, EP von Strandmann, M Huber, T Adhikary, U Wagner, S Reinartz, R Müller
Frontiers in Oncology 2017
Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy
B Xu, J Lefringhouse, Z Liu, D West, LA Baldwin, C Ou, L Chen, D Napier, L Chaiswing, LD Brewer, DS Clair, O Thibault, JR van Nagell, BP Zhou, R Drapkin, JA Huang, ML Lu, FR Ueland, XH Yang
Oncogenesis 2017
Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis
Y Klymenko, O Kim, E Loughran, J Yang, R Lombard, M Alber, MS Stack
Oncogene 2017
Novel Intraperitoneal Treatment With Non-Thermal Plasma-Activated Medium Inhibits Metastatic Potential of Ovarian Cancer Cells
K Nakamura, Y Peng, F Utsumi, H Tanaka, M Mizuno, S Toyokuni, M Hori, F Kikkawa, H Kajiyama
Scientific Reports 2017
Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics
J Yang, WC Kasberg, A Celo, Z Liang, K Quispe, MS Stack
The Journal of biological chemistry 2017
E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
M Rosso, B Majem, L Devis, L Lapyckyj, MJ Besso, M Llauradó, MF Abascal, ML Matos, L Lanau, J Castellví, JL Sánchez, AP Benavente, A Gil-Moreno, J Reventós, AS Margalef, M Rigau, MH Vazquez-Levin, JS Castresana
PloS one 2017
Recent Advances in Understanding, Diagnosing, and Treating Ovarian Cancer
K Mills, K Fuh
F1000Research 2017
An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells
G Li, JE Montgomery, MA Eckert, JW Chang, SM Tienda, E Lengyel, RE Moellering
Nature Communications 2017
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Marcin Iwanicki, Hsing-Yu Chen, Claudia Iavarone, Ioannis Zervantonakis, Taru Muranen, Marian Novak, Tan Ince, Ronny Drapkin, Joan Brugge
JCI Insight 2016
Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors
W Chowanadisai, SM Messerli, DH Miller, JE Medina, JW Hamilton, MA Messerli, AS Brodsky, S Orsulic
PloS one 2016
Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling
S Bernaudo, M Salem, X Qi, W Zhou, C Zhang, W Yang, D Rosman, Z Deng, G Ye, B Yang, B Vanderhyden, Z Wu, C Peng
Oncogene 2016
SUSD2 expression in high-grade serous ovarian cancer correlates with increased patient survival and defective mesothelial clearance
JN Sheets, M Iwanicki, JF Liu, BE Howitt, MS Hirsch, JA Gubbels, R Drapkin, KA Egland
Oncogenesis 2016
Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
S Deng, CK Wong, HC Lai, AS Wong
Oncotarget 2016
The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate
KL Boylan, PC Buchanan, RD Manion, DM Shukla, K Braumberger, C Bruggemeyer, AP Skubitz
Oncotarget 2016
Functional characterization of a panel of high-grade serous ovarian cancer cell lines as representative experimental models of the disease
J Haley, S Tomar, N Pulliam, S Xiong, SM Perkins, AR Karpf, S Mitra, KP Nephew, AK Mitra
Oncotarget 2016
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, LM Selfors, W Liu, K Chen, M Yong, P Buchwald, B Wang, KS Hale, E Cohick, P Sergent, A Witt, Z Kozhekbaeva, S Gao, AT Agoston, MA Merritt, R Foster, BR Rueda, CP Crum, JS Brugge, GB Mills
Nature Communications 2015
EMT-Inducing Molecular Factors in Gynecological Cancers
L Campo, C Zhang, EK Breuer
BioMed Research International 2015
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis
A Rynne-Vidal, J Jiménez-Heffernan, C Fernández-Chacón, M López-Cabrera, P Sandoval
Cancers 2015
Dynamic Change in p63 Protein Expression during Implantation of Urothelial Cancer Clusters
T Yoshida, H Okuyama, M Nakayama, H Endo, Y Tomita, N Nonomura, K Nishimura, M Inoue
Neoplasia (New York, N.Y.) 2015
Imaging innate immune responses at tumour initiation: new insights from fish and flies
Y Feng, P Martin
Nature Reviews Cancer 2015
Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?
RN Sharan, ST Vaiphei, S Nongrum, J Keppen, M Ksoo
Cellular Oncology 2015
Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma
RJ Burkhalter, SD Westfall, Y Liu, MS Stack
The Journal of biological chemistry 2015
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast, V Beral, JS Berek, MJ Birrer, S Blagden, MA Bookman, JD Brenton, KB Chiappinelli, FC Martins, G Coukos, R Drapkin, R Edmondson, C Fotopoulou, H Gabra, J Galon, C Gourley, V Heong, DG Huntsman, M Iwanicki, BY Karlan, A Kaye, E Lengyel, DA Levine, KH Lu, IA McNeish, U Menon, SA Narod, BH Nelson, KP Nephew, P Pharoah, DJ Powell, P Ramos, IL Romero, CL Scott, AK Sood, EA Stronach, FR Balkwill
Nature Reviews Cancer 2015
Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome.
Rea K, Pinciroli P, Sensi M, Alciato F, Bisaro B, Lozneanu L, Raspagliesi F, Centritto F, Cabodi S, Defilippi P, Avanzi GC, Canevari S, Tomassetti A
Oncotarget 2015
Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
Hilary Kenny, Chun-Yi Chiang, Erin White, Elizabeth Schryver, Mohammed Habis, Iris Romero, Andras Ladanyi, Carla Penicka, Joshy George, Karl Matlin, Anthony Montag, Kristen Wroblewski, S. Diane Yamada, Andrew Mazar, David Bowtell, Ernst Lengyel
Journal of Clinical Investigation 2014
Three-dimensional modeling of ovarian cancer
EA White, HA Kenny, E Lengyel
Advanced Drug Delivery Reviews 2014
Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
S Zhang, B Cui, H Lai, G Liu, EM Ghia, GF Widhopf, Z Zhang, CC Wu, L Chen, R Wu, R Schwab, DA Carson, TJ Kipps
Proceedings of the National Academy of Sciences 2014
Establishment of a New Ovarian Cancer Cell Line CA5171
YC Chiang, WF Cheng, MC Chang, TP Lu, KT Kuo, HP Lin, CY Hsieh, CA Chen
Reproductive sciences (Thousand Oaks, Calif.) 2014

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Blogged by 1
Referenced in 1 patents
Highlighted by 1 platforms
125 readers on Mendeley
1 readers on CiteULike
See more details